NHS England launches pilot of rapid genomic test for brain tumour diagnosis
A UK-first pilot across specialist centres in England aims to cut the time from biopsy to definitive brain tumour diagnosis from weeks to days using genomic profiling.
NHS England has announced an expanded pilot of a rapid genomic diagnostic test for patients with suspected brain tumours, describing it as a world-first deployment at this scale within a national health service. The pilot, being rolled out across specialist neuroscience centres in England, uses genomic analysis of tumour tissue to produce a definitive classification of brain tumour type within days rather than the weeks currently required by conventional histopathology workflows.
Brain tumour diagnosis is complex: the 2021 WHO classification of central nervous system tumours is now built substantially on molecular and genomic markers alongside histological appearance. Accurate subtyping determines treatment pathway, trial eligibility, and prognosis. Delays in molecular diagnosis can therefore delay treatment decisions. The NHS pilot is designed to address this bottleneck by integrating genomic testing more tightly into the post-surgical diagnostic pathway.
NHS England has not specified in the publicly available announcement which sequencing platform or panel is being used, nor the precise number of centres involved in the initial expansion. The announcement does not constitute clinical guidance; it describes a service-evaluation pilot. Genetic counsellors and oncology teams working in neuro-oncology settings may wish to monitor NHS England updates for implementation details as the pilot progresses.
Plain-language version
For patients, families, and general readers. Educational only — not medical advice.
NHS England has announced a pilot of a faster genomic test for people who may have a brain tumour. At the moment, after a biopsy — where a small piece of the tumour is removed — it can take weeks to get a full diagnosis, because doctors need to look at the tissue carefully and also run tests on the tumour's genetic make-up. The new pilot aims to do the genetic testing much faster, so that people could get a complete diagnosis in days rather than weeks. Knowing the exact type of brain tumour more quickly helps doctors decide on the best treatment sooner. The pilot is running at specialist hospital centres in England. This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary source NHS England · 2026-09-24NHS pilots rapid genomic test to transform brain tumour diagnosis